• Latest
  • Trending
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy

9 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

DOGE Price Forecast: October 12, 2024

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

Ethereum Price Forecast for 12.10.2024: Insights & Predictions

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

LTC Price Forecast: Insights for October 12, 2024

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

SOL Price Forecast and Analysis – October 12, 2024

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

Toncoin Price Forecast and Analysis for 12.10.2024

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

XRP (Ripple) Price Forecast for October 12, 2024

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

Current Market Signals Analysis (12.10.2024 22:28)

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

Market Insights: Crypto Trends and Stock Volatility as of 12.10.2024 20:28

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

Market Trends & Social Media Insights – October 12, 2024 18:28

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

Market Signals: Insights from Financial Data & Social Media Trends – 12.10.2024 16:28

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

Stock Market Update: Insights on D-Mart’s Revenue Boost – 12.10.2024 14:28

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

ADA (Cardano) Price Forecast for October 12, 2024

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

Bitcoin Price Forecast and Market Analysis (12.10.2024)

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

DOGE Price Forecast: Insights for October 12, 2024

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

Ethereum Price Forecast and Analysis – October 12, 2024

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

LTC Price Forecast: October 12, 2024

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

SOL (Solana) Price Forecast Report – October 12, 2024

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

Toncoin (TON) Price Forecast for October 12, 2024

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

XRP Price Forecast: October 12, 2024 Predictions

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

Market Signals & Social Media Insights: October 12, 2024

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

City Approves Bond Refinancing to Cut Budget Gaps

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

Market Trends & Social Media Insights: 03-10-2024 18:33

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

Bitcoin Whale Sells $46 Million Amid Price Drop

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

Lunex Network Gains, Dogecoin and Shiba Inu Eyed

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

SEC Appeals Ruling on XRP as Non-Security

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

Market Insights: Oil and UK Stocks Shift Amid Mideast Tensions – 03.10.2024 14:33

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

Dogecoin Price Set to Surge by 180%: Key Indicators

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

Bitcoin’s Volatility Amid Geopolitical Tensions

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

BabyDoge on Binance Sparks Market Buzz – 2024-10-03 12:34

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

Ethereum Eyes Rebound Amid Middle East Tensions

7 months ago
FinOracle
GET ACCESS
  • Contacts
  • en EN
    • ar AR
    • zh-CN ZH-CN
    • en EN
    • fr FR
    • de DE
    • hi HI
    • id ID
    • it IT
    • ja JA
    • ko KO
    • pt PT
    • ru RU
    • es ES
  • Login
  • Register
  • Finance
    • All
    • Futures Analysis
    • Investing
    • Real Estate
    • Stock Market
    Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

    Market Trends & Social Media Insights – October 12, 2024 18:28

    Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

    Market Signals: Insights from Financial Data & Social Media Trends – 12.10.2024 16:28

    Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

    Stock Market Update: Insights on D-Mart’s Revenue Boost – 12.10.2024 14:28

    Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

    Market Signals & Social Media Insights: October 12, 2024

    • Investing
    • Stock Market
    • Real Estate
  • Cryptocurrency
    • All
    • Bitcoin
    • Doge
    • Ethereum
    • NFTs
    Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

    Current Market Signals Analysis (12.10.2024 22:28)

    Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

    Bitcoin Whale Sells $46 Million Amid Price Drop

    Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

    Lunex Network Gains, Dogecoin and Shiba Inu Eyed

    Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

    SEC Appeals Ruling on XRP as Non-Security

    • Bitcoin
    • Doge
    • Ethereum
    • NFTs
  • Technology
    • Virtual Reality
    • Artificial Intelligence
    • Gaming
    • Apps
  • Reports & SWOTPRO
    • Financial reports
    • SWOT’s
    • Opinion
  • PredictionsPro
    • Cryptocurrency price
    • Stocks price
  • Markets
    • Stocks
      • Basic Materials
      • Consumer Discretionary
      • Consumer Staples
      • Energy
      • Finance
      • Health Care
      • Industrials
      • Miscellaneous
      • Real Estate
      • Technology
      • Telecommunications
      • Utilities
    • Crypto
    • Forex Cross Rates
No Result
View All Result
  • Finance
    • All
    • Futures Analysis
    • Investing
    • Real Estate
    • Stock Market
    Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

    Market Trends & Social Media Insights – October 12, 2024 18:28

    Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

    Market Signals: Insights from Financial Data & Social Media Trends – 12.10.2024 16:28

    Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

    Stock Market Update: Insights on D-Mart’s Revenue Boost – 12.10.2024 14:28

    Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

    Market Signals & Social Media Insights: October 12, 2024

    • Investing
    • Stock Market
    • Real Estate
  • Cryptocurrency
    • All
    • Bitcoin
    • Doge
    • Ethereum
    • NFTs
    Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

    Current Market Signals Analysis (12.10.2024 22:28)

    Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

    Bitcoin Whale Sells $46 Million Amid Price Drop

    Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

    Lunex Network Gains, Dogecoin and Shiba Inu Eyed

    Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

    SEC Appeals Ruling on XRP as Non-Security

    • Bitcoin
    • Doge
    • Ethereum
    • NFTs
  • Technology
    • Virtual Reality
    • Artificial Intelligence
    • Gaming
    • Apps
  • Reports & SWOTPRO
    • Financial reports
    • SWOT’s
    • Opinion
  • PredictionsPro
    • Cryptocurrency price
    • Stocks price
  • Markets
    • Stocks
      • Basic Materials
      • Consumer Discretionary
      • Consumer Staples
      • Energy
      • Finance
      • Health Care
      • Industrials
      • Miscellaneous
      • Real Estate
      • Technology
      • Telecommunications
      • Utilities
    • Crypto
    • Forex Cross Rates
No Result
View All Result
FinOracle
Home Business

Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy

Kezar halts tumor drug trials, pivots to autoimmune hepatitis focus with promising zetomipzomib.

by Lilu Anderson
Wed, Aug 14, 2024 9:11pm
in Business
• 2 mins read
14.8k
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

Photo: Finoracle.net

Share on FacebookShare on Twitter

Kezar Life Sciences' Strategic Shift

Kezar Life Sciences has decided to halt the development of its phase 1 solid tumor drug known as KZR-261. This decision comes as the company chooses to focus its resources on its promising treatment for autoimmune hepatitis.

Exclusive Access: Unlock Premium, Confidential Insights

Unlock This Exclusive Content—Subscribe Instantly!

Login if you have purchased

Buy Article

Unlock this article and gain permanent access to read it.
Unlock Now
Tags: 2025ALSAntARArtAsiaAutoimmune hepatitisBitCatCESChief medical officerChinaCompanyConcentraConfidenceDiseaseDrugDrug developmentExperienceFutureHealthHopeIceInnIonKoreaLifeLupus nephritisMedicineOfficeOuncePatientPersonPHPortPotentialProgressProteinResourceResource allocationRestructuringRightsScienceSECSolidSouth KoreaSoutheast AsiaStarTeaTherapyTrialTurinUnderscoreUSXperi
Share3999Tweet2499Share700Send

Related Posts

Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

DOGE Price Forecast: October 12, 2024

7 months ago
Kezar Shifts Focus From Tumor Drug to Autoimmune Therapy | FinOracle

Ethereum Price Forecast for 12.10.2024: Insights & Predictions

7 months ago
FinOracle

We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.

Recent Posts

  • DOGE Price Forecast: October 12, 2024
  • Ethereum Price Forecast for 12.10.2024: Insights & Predictions
  • LTC Price Forecast: Insights for October 12, 2024
  • SOL Price Forecast and Analysis – October 12, 2024

Categories

  • Apps
  • Artificial Intelligence
  • Bitcoin
  • Business
  • Cryptocurrency
  • Cryptocurrency price
  • Doge
  • Economy
  • Ethereum
  • Finance
  • Financial reports
  • Futures Analysis
  • Gaming
  • Investing
  • NFTs
  • Opinion
  • Real Estate
  • Shopping
  • Sport
  • Stock Market
  • SWOT
  • Technology
  • Video
  • Virtual Reality
  • World

Tags

AI ALS Ant AR Art BET Car Cat CES Company Crypto Cryptocurrency Currency Data Demand ETH EU Experience Future Growth Ice Innovation Interest Investment Investor Ion Light Market Opportunities Ore PH Port Potential Price Ratio Rice Risk SEC Stock System Technology Time US War Xperi

© 2024 FinOracle.net - Your financial oracle, analytics and forecasts for stocks, cryptocurrency.

Welcome Back!

Continue with Google
Continue with Microsoft
OR

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Continue with Google
Continue with Microsoft
OR

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Home
Trends
Premium
Favorite
Account
No Result
View All Result
  • Finance
    • Investing
    • Stock Market
    • Real Estate
  • Cryptocurrency
    • Bitcoin
    • Doge
    • Ethereum
    • NFTs
  • Technology
    • Virtual Reality
    • Artificial Intelligence
    • Gaming
    • Apps
  • Reports & SWOT
    • Financial reports
    • SWOT’s
    • Opinion
  • Predictions
    • Cryptocurrency price
    • Stocks price
  • Markets
    • Stocks
      • Basic Materials
      • Consumer Discretionary
      • Consumer Staples
      • Energy
      • Finance
      • Health Care
      • Industrials
      • Miscellaneous
      • Real Estate
      • Technology
      • Telecommunications
      • Utilities
    • Crypto
    • Forex Cross Rates

© 2024 FinOracle.net - Your financial oracle, analytics and forecasts for stocks, cryptocurrency.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?